Mineralocorticoid receptor blockade improves diastolic function independent of blood pressure reduction in a transgenic model of RAAS overexpression

Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension

(2013) James R. Sowers   ANNALS OF INTERNAL MEDICINE

Efecto diferencial de espironolactona frente a eplerenona sobre el papel protector in vitro de testosterona en la apoptosis de cardiocitos

(2011) Jesús Sánchez-Más et al.   REVISTA ESPANOLA DE CARDIOLOGIA

Comparative analysis of telmisartan and olmesartan on cardiac function in the transgenic (mRen2)27 rat

(2010) Vincent G. DeMarco et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Mineralocorticoid Accelerates Transition to Heart Failure With Preserved Ejection Fraction Via “Nongenomic Effects”

(2010) Selma F. Mohammed et al.   CIRCULATION

Nebivolol Improves Diastolic Dysfunction and Myocardial Remodeling Through Reductions in Oxidative Stress in the Zucker Obese Rat

(2010) Xinli Zhou et al.   HYPERTENSION

Natural History of Markers of Collagen Turnover in Patients With Early Diastolic Dysfunction and Impact of Eplerenone

(2009) George J. Mak et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effect of renin inhibition and AT1R blockade on myocardial remodeling in the transgenic Ren2 rat

(2008) Adam Whaley-Connell et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Mineralocorticoid Receptor Antagonism Attenuates Vascular Apoptosis and Injury via Rescuing Protein Kinase B Activation

(2008) Yongzhong Wei et al.   HYPERTENSION

Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions

(2008) Hong Wang et al.   JOURNAL OF HYPERTENSION